GC69281
Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody that targets human CD22· Inotuzumab can be linked to the toxin ozogamicin to create an antibody-drug conjugate (ADC)· Inotuzumab is being studied for use in acute lymphoblastic leukemia and non-Hodgkin's lymphoma
ChemicalCAS1660159-36-3
- CAS number
- 1660159-36-3
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC69281
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il